Glucagon-like peptide-1 receptor agonist use corresponded with risk reductions for dozens of diseases and adverse health ...
Medpage Today on MSN1d
GLP-1 Agents' Risks and Benefits Broader Than Previously ThoughtGLP-1 agents "have an intricate web of various effects," Al-Aly said in a press briefing. For example, the analysis showed ...
Hudson Regional Hospital’s Cardiac Catheterization Lab has earned NJ State Department of Health approval for STEMI ...
The myocardial infarction market is driven by the growing prevalence of cardiovascular diseases and advancements in diagnostics and treatments. Key factors include an aging population, ...
News Medical on MSN1d
Researchers create an atlas of health associations for GLP-1 receptor agonistsInsights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...
The association between hospital-diagnosed migraine and increased risks to cardiovascular health cannot be attributed to NSAID use.
Wearable devices can reduce cardiovascular events and death in ischemic heart disease, according to a new meta-analysis, but ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback